Cancel
Mir Hashim
Chief Scientific Officer
@
Rani Therapeutics
4y1.4lyw50@37z24v4qlq0zklgf.w1j
Sign up to see email
Known information
- Has more than 30 years of pharmaceutical research and development experience.
- Spent 18 years at Glaxo Smith Kline, where he most recently served as the head of Pharmacology.
- Has deep experience in drug discovery and development, international regulatory submissions, and international product development.
- Has experience in in-licensing and out-licensing of drug candidates.
- Holds a B.S. in Biology and Chemistry from Osmania University, India.
- Holds an M.S. in Biology from Central University of Hyderabad, India.
- Holds a PhD in Medicine/Pharmacology from Memorial University, St. John’s, Canada.
- Has a breadth of knowledge and experience in pharmacology and physiology spanning a variety of therapeutic areas including CNS, cardiovascular, gastrointestinal, anesthesia, and metabolic diseases such as diabetes and obesity.
About Rani Therapeutics
Rani Therapeutics has developed a disruptive technology for the oral delivery of biologics, aiming to replace painful injections with their innovative RaniPill platform.
Report inaccurate information
